novo retatrutide ADA: CSO says 'jury still out' on CagriSema v. Beyond GLP-1: Understanding the Next

Some countries, like Australia, have Mounjaro (the doctors first choice) pens, which allow you to determine how much of the drug to use

Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardio-vascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial

Pridal L

Using exactly 5 ml of bacteriostatic water with a 5 mg vial gives a clean 1 mg/ml concentration that math makes dose calculation simple and consistent every time you draw a syringe

For example, clinical trials found that participants taking 2.4 mg of semaglutide lost almost twice as much weight as those on 1.0 mg

As of 2025, retatrutide has not received MHRA or EMA marketing authorisation in the UK and remains in Phase 3 clinical trials